Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-22

Clinical Trial Update: Ivermectin in the Treatment of Head Lice [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ivermectin for pediculosis capitis (head lice) treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Lice Infestations | Phase 3 | Status: COMPLETED